Clinical Trials Browser

Unknown × tremelimumab × Gastrointestinal × Clear all

NCT04159974 2024-05-09

RICE

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus

NCT03377400 2020-12-17

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma